How to pay the least
Ask for the cash price
Avmapki Fakzynja Co-Pack
We didn’t find one.
- Ask your pharmacy for Avmapki Fakzynja Co-Pack’s cash price, and one or two other pharmacies too.
Compare every option
Details for each option
Brand nameNo maker’s card
We didn’t find a savings card or cash price from Avmapki Fakzynja Co-Pack’s maker. Ask the pharmacy for Avmapki Fakzynja Co-Pack’s cash price. With insurance, ask what your plan charges.
Authorized genericNot sold
There isn’t one. An authorized generic is Avmapki Fakzynja Co-Pack itself, from the same company, sold without the brand name, and usually for less. For now Avmapki Fakzynja Co-Pack is the only choice; ask the pharmacy for its cash price, or your plan what it charges.
Regular genericNot sold
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Avmapki Fakzynja Co-Pack’s cash price, or your plan what it charges.
What it’s used for
What the FDA label says
AVMAPKI FAKZYNJA CO-PACK, a combination of avutometinib and defactinib, each kinase inhibitors, is indicated for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.
This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Source: the FDA label for Avmapki Fakzynja Co-Pack (Verastem Inc.), May 1, 2025. Full label on DailyMed
Good to know
- We didn’t find a savings card from Avmapki Fakzynja Co-Pack’s maker.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/avmapki-fakzynja-co-pack/